C-X-C motif chemokine receptor type 2 correlates with higher disease stages and predicts worse prognosis, and its downregulation enhances chemotherapy sensitivity in triple-negative breast cancer

BACKGROUND: This study aimed to explore the correlation of C-X-C motif chemokine receptor type 2 (CXCR2) expression with tumor stage and overall survival (OS) in triple-negative breast cancer (TNBC) patients, furthermore, to investigate the influence of CXCR2 downregulation on chemotherapy sensitivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Huimin, Li, Wenhuan, Li, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798293/
https://www.ncbi.nlm.nih.gov/pubmed/35117429
http://dx.doi.org/10.21037/tcr.2019.12.38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798293/
https://www.ncbi.nlm.nih.gov/pubmed/35117429
http://dx.doi.org/10.21037/tcr.2019.12.38

Ejemplares similares